Preclinical pharmacology of mGlu2/3 receptor agonists: novel agents for schizophrenia?

Current drug targets. CNS and neurological disorders

Volumn 1, Issue 2, 2002, Pages 215-225

  DD, Darryle D Schoepp ^a   Marek, Gerard J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR STIMULATING AGENT; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3;

ANIMAL; CHEMISTRY; DRUG POTENTIATION; DRUG SCREENING; HUMAN; METABOLISM; METHODOLOGY; REVIEW; SCHIZOPHRENIA;

ANIMALS; DRUG EVALUATION, PRECLINICAL; EXCITATORY AMINO ACID AGONISTS; HUMANS; RECEPTORS, METABOTROPIC GLUTAMATE; SCHIZOPHRENIA;

MLCS; MLOWN;

EID: 0011900802     PISSN: 1568007X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568007024606177     Document Type: Review

References (79)